300869 康泰医学
已收盘 05-08 15:00:00
资讯
新帖
简况
股市必读：康泰医学年报 - 第四季度单季净利润同比增长61.48%
证券之星 · 04-29
股市必读：康泰医学年报 - 第四季度单季净利润同比增长61.48%
图解康泰医学年报：第四季度单季净利润同比增长61.48%
证券之星 · 04-28
图解康泰医学年报：第四季度单季净利润同比增长61.48%
康泰医学(300869)3月31日股东户数3.28万户，较上期减少1.41%
证券之星 · 04-27
康泰医学(300869)3月31日股东户数3.28万户，较上期减少1.41%
康泰医学：迪拜子公司目前正在筹备阶段
证券之星 · 04-15
康泰医学：迪拜子公司目前正在筹备阶段
康泰医学：已形成院线类、家用类和其他类三大产品体系
证券之星 · 04-15
康泰医学：已形成院线类、家用类和其他类三大产品体系
康泰医学：各项整改工作正在有序推进中
证券之星 · 04-10
康泰医学：各项整改工作正在有序推进中
康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权
证券之星 · 04-04
康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权
康泰医学（300869）披露持股5%以上股东权益变动提示性公告，4月3日股价下跌3.03%
证券之星 · 04-03
康泰医学（300869）披露持股5%以上股东权益变动提示性公告，4月3日股价下跌3.03%
康泰医学（300869）披露股东询价转让定价情况提示性公告，3月26日股价下跌1.72%
证券之星 · 03-26
康泰医学（300869）披露股东询价转让定价情况提示性公告，3月26日股价下跌1.72%
康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份
智通财经 · 03-25
康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份
康泰医学（300869）披露公司产品获得CE证书公告，3月2日股价下跌3.04%
证券之星 · 03-02
康泰医学（300869）披露公司产品获得CE证书公告，3月2日股价下跌3.04%
康泰医学（300869）披露关于使用闲置自有资金进行现金管理的公告，2月26日股价下跌1.96%
证券之星 · 02-26
康泰医学（300869）披露关于使用闲置自有资金进行现金管理的公告，2月26日股价下跌1.96%
康泰医学（300869）披露2025年度业绩预亏公告，2月4日股价上涨0.32%
证券之星 · 02-04
康泰医学（300869）披露2025年度业绩预亏公告，2月4日股价上涨0.32%
康泰医学（300869）披露2025年度业绩预告，1月30日股价下跌1.34%
证券之星 · 01-30
康泰医学（300869）披露2025年度业绩预告，1月30日股价下跌1.34%
康泰医学（300869）披露2025年第四季度可转换公司债券转股情况，1月5日股价上涨4.27%
证券之星 · 01-05
康泰医学（300869）披露2025年第四季度可转换公司债券转股情况，1月5日股价上涨4.27%
科力装备：为康泰医学开发额温枪部件
证券之星 · 2025-12-01
科力装备：为康泰医学开发额温枪部件
康泰医学（300869）披露迪拜子公司成立进展，11月26日股价上涨0.06%
证券之星 · 2025-11-26
康泰医学（300869）披露迪拜子公司成立进展，11月26日股价上涨0.06%
11月24日康泰医学发布公告，股东减持81.66万股
证券之星 · 2025-11-24
11月24日康泰医学发布公告，股东减持81.66万股
康泰医学：11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股
证券之星 · 2025-11-21
康泰医学：11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股
康泰医学：11月19日高管寇国治减持股份合计5.9万股
证券之星 · 2025-11-20
康泰医学：11月19日高管寇国治减持股份合计5.9万股
公司概况
公司名称：
康泰医学系统(秦皇岛)股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-08-24
主营业务：
康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是家用类产品、院线类产品、其他类产品。
发行价格：
10.16
{"stockData":{"symbol":"300869","market":"SZ","secType":"STK","nameCN":"康泰医学","latestPrice":13.06,"timestamp":1778223804000,"preClose":12.79,"halted":0,"volume":6414762,"delay":0,"changeRate":0.0211,"floatShares":264000000,"shares":401999999,"eps":-0.1223,"marketStatus":"已收盘","change":0.27,"latestTime":"05-08 15:00:00","open":12.79,"high":13.27,"low":12.75,"amount":84081400,"amplitude":0.0407,"askPrice":13.07,"askSize":126,"bidPrice":13.06,"bidSize":141,"shortable":0,"etf":0,"ttmEps":-0.1223,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":5,"adr":0,"adjPreClose":12.79,"symbolType":"stock","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":14.07,"lowLimit":11.51,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":401803327,"isCdr":false,"pbRate":3.03,"roa":"--","roe":"--","epsLYR":-0.06,"committee":0.172057,"marketValue":5248000000,"turnoverRate":0.0243,"status":0,"floatMarketCap":3450000000},"requestUrl":"/m/hq/s/300869/wiki","defaultTab":"wiki","newsList":[{"id":"2631537465","title":"股市必读：康泰医学年报 - 第四季度单季净利润同比增长61.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537465","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537465?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:11","pubTimestamp":1777417895,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，康泰医学报收于12.6元，下跌3.3%，换手率1.98%，成交量5.24万手，成交额6678.19万元。业绩披露要点康泰医学2025年年报显示，当年度公司主营收入4.68亿元，同比下降2.46%；归母净利润-2442.39万元，同比上升68.65%；扣非净利润-4734.23万元，同比上升50.21%；其中2025年第四季度，公司单季度主营收入1.24亿元，同比下降15.01%；单季度归母净利润-3382.37万元，同比上升61.48%；单季度扣非净利润-4394.51万元，同比上升50.41%；负债率37.46%，投资收益1672.91万元，财务费用405.68万元，毛利率48.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900019010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630804319","title":"图解康泰医学年报：第四季度单季净利润同比增长61.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630804319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630804319?lang=zh_cn&edition=full","pubTime":"2026-04-28 01:09","pubTimestamp":1777309767,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学2025年年报显示，当年度公司主营收入4.68亿元，同比下降2.46%；归母净利润-2442.39万元，同比上升68.65%；扣非净利润-4734.23万元，同比上升50.21%；其中2025年第四季度，公司单季度主营收入1.24亿元，同比下降15.01%；单季度归母净利润-3382.37万元，同比上升61.48%；单季度扣非净利润-4394.51万元，同比上升50.41%；负债率37.46%，投资收益1672.91万元，财务费用405.68万元，毛利率48.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800003192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630799361","title":"康泰医学(300869)3月31日股东户数3.28万户，较上期减少1.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630799361","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630799361?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:32","pubTimestamp":1777282339,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学披露，截至2026年3月31日公司股东户数为3.28万户，较12月31日减少469.0户，减幅为1.41%。在医疗器械行业个股中，康泰医学股东户数高于行业平均水平，截至3月31日，医疗器械行业平均股东户数为2.19万户。从股价来看，2025年12月31日至2026年3月31日，康泰医学区间跌幅为11.53%，在此期间股东户数减少469.0户，减幅为1.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700032148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472509","title":"康泰医学：迪拜子公司目前正在筹备阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472509","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472509?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:33","pubTimestamp":1776223987,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学(300869)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的中东分公司，有无受到战争影响？后期战后医疗重建是否会受益？康泰医学回复：尊敬的投资者您好，公司新设立的迪拜子公司目前正在筹备阶段，区域局势变化对中东地区物流运输等方面有一定影响。公司将密切关注国际局势及市场环境变化，稳步推进海外业务。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627472577","title":"康泰医学：已形成院线类、家用类和其他类三大产品体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2627472577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627472577?lang=zh_cn&edition=full","pubTime":"2026-04-15 11:33","pubTimestamp":1776223986,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学(300869)04月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的主力产品有哪些？是否具备业务护城河能力？康泰医学回复：尊敬的投资者您好，公司已经形成院线类、家用类和其他类三大产品体系，涵盖血氧类、心电类、超声类、监护类、血压类、分析测试类等多类产品。公司深耕行业多年，在研发创新、全产业链、营销网络等方面逐渐形成了自身的综合优势，为公司稳健发展提供了有力支撑。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500018722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626154508","title":"康泰医学：各项整改工作正在有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2626154508","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626154508?lang=zh_cn&edition=full","pubTime":"2026-04-10 09:00","pubTimestamp":1775782858,"startTime":"0","endTime":"0","summary":"证券之星消息，康泰医学(300869)04月09日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘请问什么时候才能解除FDA警告信？康泰医学回复：尊敬的投资者您好！公司收到FDA警告信后，已在规定时间内向FDA提交了正式回复及整改计划，各项整改工作正在有序推进中，公司与FDA始终保持着密切沟通，争取尽快关闭警告信。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000007702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624669977","title":"康泰医学新注册《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624669977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624669977?lang=zh_cn&edition=full","pubTime":"2026-04-04 02:05","pubTimestamp":1775239517,"startTime":"0","endTime":"0","summary":"证券之星消息，近日康泰医学新注册了《CA20M呼气末二氧化碳监测仪软件V1.0》项目的软件著作权。今年以来康泰医学新注册软件著作权5个，较去年同期减少了95.61%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4648.11万元，同比减17.08%。通过天眼查大数据分析，康泰医学系统（秦皇岛）股份有限公司共对外投资了7家企业，参与招投标项目472次；财产线索方面有商标信息85条，专利信息663条，著作权信息430条；此外企业还拥有行政许可275个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040400000562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159180","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624465486","title":"康泰医学（300869）披露持股5%以上股东权益变动提示性公告，4月3日股价下跌3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624465486","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624465486?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:34","pubTimestamp":1775212455,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，康泰医学报收于13.1元，较前一交易日下跌3.03%，最新总市值为52.64亿元。该股当日开盘13.45元，最高13.58元，最低13.07元，成交额达4212.95万元，换手率为1.21%。近日，康泰医学披露《股东询价转让结果报告书暨持股5%以上股东持有权益比例降至5%以下的提示性公告》。公告显示，公司持股5%以上股东王桂丽通过集中竞价、大宗交易及询价转让方式减持公司股份，合计持股比例由10.00%下降至4.9999%，持股比例降至5%以下。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622691869","title":"康泰医学（300869）披露股东询价转让定价情况提示性公告，3月26日股价下跌1.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622691869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622691869?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:35","pubTimestamp":1774535718,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，康泰医学报收于13.11元，较前一交易日下跌1.72%，最新总市值为52.68亿元。康泰医学系统（秦皇岛）股份有限公司于2026年3月26日发布《股东询价转让定价情况提示性公告》。本次拟转让股份已获全额认购，初步确定受让方为15家机构投资者，受让股份总数为15,037,100股。本次转让不通过二级市场进行，受让方6个月内不得转让所受让股份。本次转让不涉及公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600044705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622026022","title":"康泰医学(300869.SZ)股东王桂丽拟询价转让3.74%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026022","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622026022?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:01","pubTimestamp":1774429292,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康泰医学(300869.SZ)发布股东询价转让计划书，拟参与公司首发前股东询价转让的股东为王桂丽，出让方拟转让股份的总数为1503.71万股，占公司当前总股本的比例为3.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616415356","title":"康泰医学（300869）披露公司产品获得CE证书公告，3月2日股价下跌3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616415356","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616415356?lang=zh_cn&edition=full","pubTime":"2026-03-02 23:15","pubTimestamp":1772464518,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，康泰医学报收于14.66元，较前一交易日下跌3.04%，最新总市值为58.9亿元。该股当日开盘14.9元，最高14.96元，最低14.66元，成交额达5810.6万元，换手率为1.55%。康泰医学系统（秦皇岛）股份有限公司于近日取得由TV SD Product Service GmbH签发的CE证书，产品名称为Insect bite helper，注册分类为IIa类。该产品获得CE证书表明其符合欧盟相关要求，已具备进入欧盟市场的准入条件，对公司未来经营将产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040462.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614023838","title":"康泰医学（300869）披露关于使用闲置自有资金进行现金管理的公告，2月26日股价下跌1.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614023838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614023838?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:36","pubTimestamp":1772116580,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，康泰医学报收于15.03元，较前一交易日下跌1.96%，最新总市值为60.39亿元。康泰医学系统（秦皇岛）股份有限公司于2026年2月26日召开第四届董事会第二十五次会议，审议通过《关于使用闲置自有资金进行现金管理的议案》，同意公司使用总额度不超过人民币2亿元（含本数）的闲置自有资金进行现金管理，期限自董事会审议通过之日起12个月内有效，资金可循环滚动使用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608410398","title":"康泰医学（300869）披露2025年度业绩预亏公告，2月4日股价上涨0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608410398","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608410398?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:39","pubTimestamp":1770215959,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，康泰医学报收于15.58元，较前一交易日上涨0.32%，最新总市值为62.6亿元。该股当日开盘15.53元，最高15.6元，最低15.38元，成交额达4986.38万元，换手率为1.27%。近日，康泰医学系统（秦皇岛）股份有限公司披露《2025年度业绩预告》。业绩变动主要原因为2025年度计提存货减值准备金额较上年减少，导致同比减亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400041788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607853042","title":"康泰医学（300869）披露2025年度业绩预告，1月30日股价下跌1.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607853042","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607853042?lang=zh_cn&edition=full","pubTime":"2026-01-30 23:13","pubTimestamp":1769785992,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，康泰医学报收于15.43元，较前一交易日下跌1.34%，最新总市值为62亿元。该股当日开盘15.65元，最高15.8元，最低15.36元，成交额达7239.53万元，换手率为1.84%。康泰医学系统（秦皇岛）股份有限公司于近日披露《2025年度业绩预告》。本期业绩变动主要因计提存货减值准备金额较上年减少。本次业绩预告未经会计师事务所审计，最终数据以2025年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000048124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601838816","title":"康泰医学（300869）披露2025年第四季度可转换公司债券转股情况，1月5日股价上涨4.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601838816","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601838816?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:09","pubTimestamp":1767625754,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，康泰医学报收于15.64元，较前一交易日上涨4.27%，最新总市值为62.84亿元。该股当日开盘14.99元，最高15.65元，最低14.98元，成交额达1.08亿元，换手率为2.74%。近日，康泰医学系统（秦皇岛）股份有限公司发布关于2025年第四季度可转换公司债券转股情况的公告。公告显示，2025年第四季度，共有1张“康医转债”完成转股，票面金额100元，合计转为3股“康泰医学”股票。公司总股本因转股增加3股，其他股份未发生变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588741006","title":"科力装备：为康泰医学开发额温枪部件","url":"https://stock-news.laohu8.com/highlight/detail?id=2588741006","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588741006?lang=zh_cn&edition=full","pubTime":"2025-12-01 15:04","pubTimestamp":1764572659,"startTime":"0","endTime":"0","summary":"证券之星消息，科力装备12月01日在投资者关系平台上答复投资者关心的问题。财报显示贵司积极拓展医疗器械（额温枪）等非汽车零部件领域。2020 年初，外部不利因素的出现，医疗器械企业康泰医学的额温枪产品供不应求，其原有额温枪结构件供应商产能难以支撑爆发式增长的订单。公司应康泰医学的紧急求助，为其开发模具和生产额温枪整体结构部件和脉搏血氧仪壳体部件。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100012186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301552","300869","BK0264","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586258897","title":"康泰医学（300869）披露迪拜子公司成立进展，11月26日股价上涨0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258897","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258897?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:48","pubTimestamp":1764150515,"startTime":"0","endTime":"0","summary":"截至2025年11月26日收盘，康泰医学报收于16.68元，较前一交易日上涨0.06%，最新总市值为67.02亿元。该股当日开盘16.65元，最高17.27元，最低16.61元，成交额达9238.99万元，换手率为2.15%。公司近日发布公告称，其在迪拜设立子公司的事项已取得新进展。根据公告，康泰医学系统（秦皇岛）股份有限公司已于近期完成子公司CONTEC GLOBAL INVESTMENT FZCO的注册并取得贸易许可证。此次对外投资事项已于2025年7月14日经公司第四届董事会第二十次会议审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300869"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585619054","title":"11月24日康泰医学发布公告，股东减持81.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585619054","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585619054?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:01","pubTimestamp":1763985671,"startTime":"0","endTime":"0","summary":"证券之星消息，11月24日康泰医学发布公告《康泰医学:关于持股5%以上股东、部分董事及高级管理人员减持计划实施完毕的公告》，其股东王桂丽于2025年10月16日至2025年11月24日间合计减持81.66万股，占公司目前总股本的0.2032%，变动期间该股股价上涨1.47%，截止11月24日收盘报16.56元。股东增减持详情见下表：根据康泰医学2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400030272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585439241","title":"康泰医学：11月20日高管杨志山、郑敏、寇国治、许云龙减持股份合计4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585439241","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585439241?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:03","pubTimestamp":1763730184,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月21日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月20日公司董事,高管杨志山、董秘,高管郑敏、高管寇国治、高管许云龙共减持公司股份4000.0股，占公司总股本为0.0008%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100037414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584131062","title":"康泰医学：11月19日高管寇国治减持股份合计5.9万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2584131062","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584131062?lang=zh_cn&edition=full","pubTime":"2025-11-20 21:03","pubTimestamp":1763643781,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月20日市场公开信息、上市公司公告及交易所披露数据整理，康泰医学最新董监高及相关人员股份变动情况：2025年11月19日公司高管寇国治共减持公司股份5.9万股，占公司总股本为0.0147%。康泰医学近半年内的董监高及核心技术人员增减持详情如下：康泰医学的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入619.14万，融资余额增加；融券净流入0.0，融券余额增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000036031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300869","BK0251"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778379532966,"stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.0411},{"period":"3month","weight":-0.1607},{"period":"6month","weight":-0.2226},{"period":"1year","weight":-0.0489},{"period":"ytd","weight":-0.1293}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康泰医学系统(秦皇岛)股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"32816人(较上一季度减少1.41%)","perCapita":"8049股","listingDate":"2020-08-24","address":"河北省秦皇岛市海港区经济技术开发区秦皇西大街112号","registeredCapital":"40180万元","survey":" 康泰医学系统(秦皇岛)股份有限公司的主营业务是医疗诊断、监护设备的研发、生产和销售。公司的主要产品是家用类产品、院线类产品、其他类产品。","listedPrice":10.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康泰医学,300869,康泰医学股票,康泰医学股票老虎,康泰医学股票老虎国际,康泰医学行情,康泰医学股票行情,康泰医学股价,康泰医学股市,康泰医学股票价格,康泰医学股票交易,康泰医学股票购买,康泰医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康泰医学(300869)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康泰医学(300869)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}